TSVT
2seventy Bio, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website 2seventybio.com
- Employees(FY) 425
- ISIN US9013841070
Performance
+8.23%
1W
-1.23%
1M
-20.0%
3M
+126.95%
6M
+12.41%
YTD
-58.04%
1Y
Profile
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and chimeric antigen receptor-T cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
Technical Analysis of TSVT 2024-05-10
Overview:
In analyzing the technical indicators for TSVT over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming trading days.
Trend In...
Recent News & Updates
- 2024-05-12 03:24
5 Penny Stocks with Insider Buying in 2024(Insidermonkey)
- 2024-05-07 23:57
- 2024-05-07 20:15
- 2024-05-07 19:00
- 2024-05-02 19:00
- 2024-04-23 22:01
- 2024-04-16 23:02
- 2024-04-04 21:05
- 2024-03-31 19:30
- 2024-03-20 05:04
- 2024-03-15 06:27
- 2024-03-06 20:10
- 2024-03-04 18:53
- 2024-03-04 18:00
- 2024-03-03 19:56
- 2024-02-29 18:00
- 2024-02-26 19:00
- 2024-02-05 03:05
- 2024-02-04 17:59
- 2024-01-31 19:27
- 2024-01-30 22:11
- 2024-01-29 18:01
2seventy bio Announces New Strategic Path Forward(Businesswire)
- 2024-01-11 23:00
- 2023-12-11 06:30
- 2023-12-10 18:00
- 2023-12-06 01:00
- 2023-11-19 23:02
- 2023-11-19 17:59
- 2023-11-13 18:00
- 2023-11-09 18:00
Page 1 of 3
previousnext